796096-45-2

Basic information

• Product Name: [5-(4-dibenzofuran-4-yl-phenyl)-3-(4-methoxy-phenyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid ethyl ester
• Synonyms: [5-(4-dibenzofuran-4-yl-phenyl)-3-(4-methoxy-phenyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid ethyl ester
• CAS NO: 796096-45-2
• Molecular Weight: 504.585
• Mol File: 796096-45-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: [5-(4-dibenzofuran-4-yl-phenyl)-3-(4-methoxy-phenyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [5-(4-dibenzofuran-4-yl-phenyl)-3-(4-methoxy-phenyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid ethyl ester(796096-45-2)
• EPA Substance Registry System: [5-(4-dibenzofuran-4-yl-phenyl)-3-(4-methoxy-phenyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid ethyl ester(796096-45-2)

Safety Data

• Hazardous Substances Data: 796096-45-2(Hazardous Substances Data)

Upstream product

• 796096-44-1 [5-(4-bromo-phenyl)-3-(4-methoxy-phenyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid ethyl ester 
• 100124-06-9 4-dibenzofurylboronic acid 

Downstream Products

• 796095-53-9 [5-(4-dibenzofuran-4-yl-phenyl)-3-(4-methoxy-phenyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid 

Relevant articles and documents

Heterocycle substituted carboxylic acids

The present invention relates to compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention includ